InvestSMART

ALS Limited (ASX:ALQ)

ALERT: Price-sensitive ASX Announcement for ALQ
Current share price for ALQ : $22.010 0.52 (2.42%)+
Announcement
Release
18 Nov 2025 8:15AM
Price at Release
$21.490
Full Release
download
Summary
ALS Limited reported strong financial results for the first half of FY26, with a 13.3% increase in underlying revenue to $1.7 billion, driven by significant growth in the Commodities sector. The underlying EBIT rose by 14.7% to $287.2 million, with a strengthening EBIT margin. Commodities experienced robust performance, especially in Minerals, maintaining a resilient margin despite prior price discounting. Life Sciences also contributed positively, led by strong results in the Food segment and Nuvisan's improved performance. The company's capital management strategy remains disciplined, with significant investments in hub lab expansions and a focus on reducing net debt, which now stands at $1,150.6 million. ALS declared an interim dividend of 19.4 cents per share, reflecting a 2.6% increase from the previous year. The company remains well-positioned for continued growth, targeting substantial revenue and EBIT increases by FY27.
Key Points
  • Underlying revenue increased by 13.3% to $1.7 billion.
  • Commodities driven by a 14.3% revenue growth and resilient margins.
  • Life Sciences led by strong food sector results, with Nuvisan showing improved margins.
  • Underlying EBIT rose by 14.7% to $287.2 million.
  • Interim dividend declared at 19.4 cents per share, a 2.6% increase.
  • Group liquidity exceeds $550 million with an 88% EBITDA cash conversion.
  • Net debt reduced to $1,150.6 million after equity raise.
  • Focus on continued strong cash generation and strategic capital allocation.
  • ALS is targeting FY27 revenue of $3.3 billion and EBIT of $600 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.